Selling software into a health system means satisfying a clinician that it helps, an IT and security function that it is safe, a privacy officer that the data handling is lawful, and a finance committee that it is worth the money. Marketing aimed only at the clinician produces enthusiasm that dies in procurement.
Publish the material the evaluation actually asks for
Security documentation, the data flows, where information is stored, the certifications held, the interoperability standards supported and the terms under which protected health information is handled. Most of this is treated as sales collateral and hidden behind a form; publishing it shortens evaluations and is exactly what a technical searcher is looking for. It also pre-qualifies: buyers who cannot live with your architecture leave before they occupy a sales cycle.
Claims about clinical benefit need evidence
Health-related claims must be substantiated, and the standard for claims about health outcomes is high. If a claim concerns diagnosis or treatment it may also engage device regulation. Decide with counsel which claims you can make, and write the marketing so the strongest sentence is one you can defend, rather than discovering the limit during a review.
Patient data may not be used for marketing by default
Protected health information cannot be used for marketing without an authorisation in most cases, which constrains targeting, list building and remarketing in ways that surprise teams used to ordinary software marketing. If your product touches patient data, the rule applies to your own use of it, not only to your customers'.
Reference customers are the currency
Health systems buy what comparable systems already run. Named references, published implementations and conference presence do more than advertising. Negotiate the right to name the customer at contract signature rather than asking a year later, when the sponsor has moved on and the communications team says no.
Questions people ask about healthcare technology marketing
Should security documentation be gated?
A summary should be public; the detailed pack can reasonably sit behind a request. Gating everything slows evaluations and hides you from the searchers doing the evaluating.
Who is the real decision maker?
Usually a committee. The clinician champions, IT and security can veto, privacy constrains, and finance decides. Marketing has to serve all four.
Can we advertise to clinicians by specialty?
Generally yes through professional channels, subject to platform policies on sensitive categories. Targeting built from patient data is a different question and is restricted.
How long is a typical sales cycle?
Long, often more than a year for an enterprise system. Plan measurement around pipeline stages rather than monthly conversions.